Mercknewsroom.com

Merck Newsroom. Merck's online newsroom offers real-time news about Merck's prescription medicines, vaccines and consumer care...

Never miss Mercknewsroom.com updates: Start reading the news feed of Merck Newsroom right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Mercknewsroom.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Merck Newsroom

Subscribe to related news

StayWell to exhibit patient engagement technology solutions at HiMSS 2017
via staywell

News release (For Immediate release) StayWell to exhibit patient engagement technology solutions at HiMSS 2017 Demonstrations of new SMART on FHIR app for Krames CareEngageTM, on-demand video capabilities, and hospital marketing solutions to be...
Atheronova, Inc. (AHRO: OTCQB) | AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Athe...
via hotstockcafe

IRVINE, Calif., June 25, 2013 /PRNewswire/ — AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement...
Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial
via military-technologies

IndiaNAPOLIS and KENILWORTH, N.J., Nov. 19, 2015 /satPRnews.com/ -- Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the...
Merck Publishes 2014 Global Corporate Responsibility Report
via mysocialgoodnews

Online Report Demonstrates Commitment to Operating as a Responsible Business and Highlights Progress in Addressing Global Health and Development Challenges KENILWORTH, N.J.–(BUSINESS WIRE) — Merck (NYSE:MRK), known as MSD outside the United States and...
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goa...
via diversityinc

Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals Merkerson Visits Washington, D.C. on June 26 With America’s Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION...

Mercknewsroom.com popular pages

Media - Merck.com

Merck's online newsroom offers real-time news about Merck's prescription medicines, vaccines and consumer care products.
Merck Newsroom Home

Merck's online newsroom allows journalists, consumers and investors to find real-time news about Merck's prescription medicines, vaccines and consumer care products.

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that new analyses from the investigational IMPROVE-IT (IMProved Reduction of Out...